Stocks To Buy Now

Blog


3rd Annual Roth Healthcare Opportunities Conference To Open New Avenues

The 3rd Annual Roth Healthcare Opportunities Conference will be held at the Metropolitan Club in New York, NY on October 9, 2024. Healthcare professionals, executives, businesses, industries, and investors of the allied healthcare sectors are invited for a full day of networking, learning and collaboration with peers and industry leaders.

This event focuses on an extensive format where executives and professionals from the Biotechnology, Brain Disorders, Medical Technologies, Oncology Therapeutics, and Pharmaceuticals sectors, gain deep insights into each other’s work portfolios.

The conference will cover small group meetings where companies and investors can interact and get a clear understanding of respective goals and work. Experts will conduct discussions on Themed Industry Panels with selected companies. The small group meetings will be in a 1-on-1 format, consisting of 25-minute management-investor meetings with extensive interaction.

The Roth conference is designed to provide a robust forum for upcoming healthcare industries and service providers to showcase their innovative ideas, technology, products, and services. C-level executives representing public and private healthcare can connect with investors for collaborative discussions.

This conference offers a tremendous opportunity for healthcare executives to present their unique company qualities to a crowd consisting of top investors and industry leaders. These meetings could well pave the way to discover new avenues and seal lucrative deals.

Recreational events are also a part of Roth events to encourage interaction among the attendees. The lunch panel will be followed by a cocktail reception.

To learn more, please visit https://ibn.fm/1LfAT

From Our Blog

Why 2026 Is a Pivotal Year for Private, Pre-IPO, and Microcap Investing, and What That Means for DealFlow Discovery

January 23, 2026

As we head into January 2026, the capital markets landscape is in a period of subtle but consequential transition, one that has real implications for the direction of private company financings, pre-public valuations, and the small-cap ecosystem that DealFlow Discovery Conference now reflects. For years, microcap investing sat at the intersection of retail enthusiasm and […]

Rotate your device 90° to view site.